P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1... by Y. Lin, T. Martin, J. G. Berdeja, A. Jakubowiak, M. Agha, A. D. Cohen, A. Deol, M. Htut, A. Lesokhin, N. C. Munshi, E. O’Donnell, C. C. Jackson, T.-M. Yeh, A. Banerjee, E. Zudaire, D. Madduri, C. Zhou, L. Pacaud, S. Z. Usmani, S. Jagannath

Get full text

P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM by Y. Wang, P. Jain, F. Locke, M. Maurer, M. Frank, J. Munoz, S. Dahiya, A. Beitinjaneh, M. Jacobs, J. Mcguirk, J. Vose, A. Goy, C. Andreadis, B. Hill, K. Dorritie, O. Oluwole, A. Deol, B. Shah, J. Paludo, T. Wang, R. Banerjee, S. Neelapu, D. Miklos, A. Rapoport, L. Lekakis, A. Ghobadi, Y. Lin, M. Wang, M. Jain

Get full text